[1] ZHAO F Y, YUE Y Y, LI L, et al. Clinical practice guidelines for post-stroke depression in China[J]. Braz J Psychiatry, 2018, 40(3): 325-334. DOI: 10.1590/1516-4446-2017-2343. [2] BARTOLI F, LILLIA N, LAX A, et al. Depression after stroke and risk of mortality: a systematic review and meta-analysis[J]. Stroke Res Treat, 2013, 2013: 862978. DOI: 10.1155/2013/862978. [3] TOWFIGHI A, OVBIAGELE B, EL HUSSEINI N, et al. Poststroke depression: a scientific statement for healthcare professionals from the American heart association/American stroke association[J]. Stroke, 2017, 48(2): e30-e43. DOI: 10.1161/STR.0000000000000113. [4] MEDEIROS G C, ROY D, KONTOS N, et al. Post-stroke depression: a 2020 updated review[J]. Gen Hosp Psychiatry, 2020, 66: 70-80. DOI: 10.1016/j.genhosppsych.2020.06.011. [5] 祁杰, 张磊,邓丽君,等.卒中后抑郁患者脑白质纤维束改变及其与抑郁程度的相关性研究[J].中国全科医学, 2022, 25(9): 1123-1129, 1135. DOI: 10.12114/j.issn.1007-9572.2021.02.079. [6] ZHANG Y, ZHAO H, FANG Y, et al. The association between lesion location, sex and poststroke depression: Meta-analysis[J]. Brain Behav, 2017, 7(10): e00788. DOI: 10.1002/brb3.788. [7] LÓPEZ-ESPUELA F, RONCERO-MARTÍN R, CANAL-MACÍAS M L, et al. Depressed mood after stroke: predictive factors at six months follow-up[J]. Int J Environ Res Public Health, 2020, 17(24): E9542. DOI: 10.3390/ijerph17249542. [8] OESTREICH L K L, WRIGHT P, O'SULLIVAN M J. Microstructural changes in the reward system are associated with post-stroke depression[J]. Neuroimage Clin, 2020, 28: 102360. DOI: 10.1016/j.nicl.2020.102360. [9] GUO J L, WANG J J, SUN W, et al. The advances of post-stroke depression: 2021 update[J]. J Neurol, 2022, 269(3): 1236-1249. DOI: 10.1007/s00415-021-10597-4. [10] WANG Y K, LIU H Y, JIANG Y, et al. Meta-analysis of 5-hydroxytryptamine transporter gene promoter region polymorphism and post-stroke depression[J]. J Int Med Res, 2020, 48(6): 300060520925943. DOI: 10.1177/0300060520925943. [11] ZAHRAI A, VAHID-ANSARI F, DAIGLE M, et al. Fluoxetine-induced recovery of serotonin and norepinephrine projections in a mouse model of post-stroke depression[J]. Transl Psychiatry, 2020, 10(1): 334. DOI: 10.1038/s41398-020-01008-9. [12] 张伟,刘鹏,袁媛,等.阻断谷氨酸-谷氨酰胺循环对大鼠脑缺血-再灌注损伤的神经保护作用[J].中国脑血管病杂志, 2016, 13(4): 198-203. DOI: 10.3969/j.issn.1672-5921.2016.04.007. [13] LI Y, ZHANG X, CHEN L X, et al. Cerebellar fastigial nucleus is involved in post-stroke depression through direct cerebellar-hypothalamic GABAergic and glutamatergic projections[J]. Exp Ther Med, 2019, 18(4): 2885-2892. DOI: 10.3892/etm.2019.7913. [14] GRUENBAUM B F, KUTZ R, ZLOTNIK A, et al. Blood glutamate scavenging as a novel glutamate-based therapeutic approach for post-stroke depression[J]. Ther Adv Psychopharmacol, 2020, 10: 2045125320903951. DOI: 10.1177/2045125320903951. [15] 谢晓彬,张卫.卒中后抑郁病因机制研究进展[J].中医临床研究, 2020, 12(5): 145-148. DOI: 10.3969/j.issn.1674-7860.2020.05.058. [16] ZHOU L, WANG T, YU Y W, et al. The etiology of poststroke-depression: a hypothesis involving HPA axis[J]. Biomed Pharmacother, 2022, 151: 113146. DOI: 10.1016/j.biopha.2022.113146. [17] WANG Z, SHI Y M, LIU F F, et al. Diversiform etiologies for post-stroke depression[J]. Front Psychiatry, 2019, 9: 761. DOI: 10.3389/fpsyt.2018.00761. [18] 孙李晴,江依勇,蔡溢,等.血清皮质醇、NLR、IGF-1及IL-6在脑卒中后抑郁中的表达及临床价值分析[J].精神医学杂志, 2021, 34(4): 308-311. DOI: 10.3969/j.issn.2095-9346.2021.04.005. [19] LEVADA O A, TROYAN A S. Poststroke depression biomarkers: a narrative review[J]. Front Neurol, 2018, 9: 577. DOI: 10.3389/fneur.2018.00577. [20] NOONAN K, CAREY L M, CREWTHER S G. Meta-analyses indicate associations between neuroendocrine activation, deactivation in neurotrophic and neuroimaging markers in depression after stroke[J]. J Stroke Cerebrovasc Dis, 2013, 22(7): e124-e135. DOI: 10.1016/j.jstrokecerebrovasdis.2012.09.008. [21] 罗爱华,卢长东,王任昌,等.血清肥胖抑制素、脑源性神经营养因子水平与缺血性脑卒中并发抑郁的关系[J].中西医结合心脑血管病杂志, 2022, 20(1): 135-140. DOI: 10.12102/j.issn.1672-1349.2022.01.029. [22] XU H B, XU Y H,HE Y, et al. Decreased serum brain-derived neurotrophic factor may indicate the development of poststroke depression in patients with acute ischemic stroke: a meta-analysis[J]. J Stroke Cerebrovasc Dis, 2018, 27(3): 709-715. DOI: 10.1016/j.jstrokecerebrovasdis.2017.10.003. [23] 傅晓艳,陈浩浩,丁明星,等.大鼠海马过表达脑源性神经营养因子对脑卒中后抑郁行为的影响[J].解剖学杂志, 2015, 38(6): 689-693. DOI: 10.3969/j.issn.1001-1633.2015.06.013. [24] BAO M H, ZHU S Z,GAO X Z, et al. Meta-analysis on the association between brain-derived neurotrophic factor polymorphism rs6265 and ischemic stroke, poststroke depression[J]. J Stroke Cerebrovasc Dis, 2018, 27(6): 1599-1608. DOI: 10.1016/j.jstrokecerebrovasdis.2018.01.010. [25] ZHANG Z, XIA D J, XU A D. Therapeutic effect of fastigial nucleus stimulation is mediated by the microRNA-182 & microRNA-382/BDNF signaling pathways in the treatment of post-stroke depression[J]. Biochem Biophys Res Commun, 2022, 627: 137-145. DOI: 10.1016/j.bbrc.2022.05.038. [26] KOO Y S, KIM H, PARK J H, et al. Indoleamine 2,3-dioxygenase-dependent neurotoxic kynurenine metabolism contributes to poststroke depression induced in mice by ischemic stroke along with spatial restraint stress[J]. Oxid Med Cell Longev, 2018, 2018: 2413841. DOI: 10.1155/2018/2413841. [27] 唐文静,伍思源,杨晨,等.炎症反应与卒中后抑郁[J].中国组织工程研究, 2022, 26(8):1278-1285. [28] ZHANG L, ZHAO M K, SUI R B. Cerebellar fastigial nucleus electrical stimulation alleviates depressive-like behaviors in post-stroke depression rat model and potential mechanisms[J]. Cell Physiol Biochem, 2017, 41(4): 1403-1412. DOI: 10.1159/000467940. [29] ELMACI I, ALTINOZ M A, SARI R. Immune pathobiology of schwannomas: a concise review[J]. J Neurol Surg A Cent Eur Neurosurg, 2018, 79(2): 159-162. DOI: 10.1055/s-0037-1603949. [30] 罗勇.海马在高温高湿应激致大鼠HPA轴功能紊乱中的作用及其药物干预研究[D].上海: 中国人民解放军海军军医大学, 2019: 42-47. [31] 周晶,蒲圣雄,付红梅.急性脑梗死后抑郁患者血清iNOS, MIP-1α水平变化及其临床意义[J].卒中与神经疾病, 2021, 28(1): 58-61, 66. DOI: 10.3969/j.issn.1007-0478.2021.01.012. [32] 刘晓溪.iNOS、MIP-1α与急性脑梗死后抑郁的相关性研究[D].保定: 河北大学, 2019: 3-9 [33] SHAN W Y, XU L, QIU Z Y, et al. Increased high-mobility group box 1 levels are associated with depression after acute ischemic stroke[J]. Neurol Sci, 2022, 43(5): 3131-3137. DOI: 10.1007/s10072-021-05571-x. [34] 樊军,樊建军.卒中后抑郁患者血清miR-223-3p和HMGB1的表达及诊断价值[J].河南医学研究, 2021, 30(29): 5404-5408. DOI: 10.3969/j.issn.1004-437X.2021.29.008. |